Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
Clinical Pharmacology and Therapeutics
|
February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugs
R Simon, G M Blumenthal, M L Rothenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction
J A Ajani, J A Roth, M B Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma
R Pazdur, D F Moore, B Bready, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1990
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma
R Pazdur, J A Ajani, Y Z Patt, et al.
Anti-Cancer Drugs
|
July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer
F Ravandi, M E Rytting, C Osmon, et al.
Cancer
|
February 15, 1990
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study
R M O'Bryan, J J Crowley, P N Kim, et al.
Cancer
|
November 1, 1993
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
Y Z Patt, B Yoffe, C Charnsangavej, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy
C E McCoach, G M Blumenthal, L Zhang, et al.
Investigational New Drugs
|
November 1, 1991
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas
J A Ajani, R Pazdur, R J Winn, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
Clinical Pharmacology and Therapeutics
|
February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugs
R Simon, G M Blumenthal, M L Rothenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction
J A Ajani, J A Roth, M B Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma
R Pazdur, D F Moore, B Bready, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1990
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma
R Pazdur, J A Ajani, Y Z Patt, et al.
Anti-Cancer Drugs
|
July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer
F Ravandi, M E Rytting, C Osmon, et al.
Cancer
|
February 15, 1990
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study
R M O'Bryan, J J Crowley, P N Kim, et al.
Cancer
|
November 1, 1993
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
Y Z Patt, B Yoffe, C Charnsangavej, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafur
D H Ho, W P Covington, R Pazdur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy
C E McCoach, G M Blumenthal, L Zhang, et al.
Investigational New Drugs
|
November 1, 1991
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas
J A Ajani, R Pazdur, R J Winn, et al.
Page
of 16